Locally advanced stages of squamous cancers of the head and neck (LAHNCs) acquire
high propensity for local and systemic relapse. Addition of systemic therapy as an induction …

As therapy for locoregionally advanced head and neck cancer (HNC) has evolved, treatment
has become increasingly aggressive and cure rates have risen. However, survival still …

The treatment of patients with locoregionally advanced squamous cell cancer of the head
and neck is still evolving. Induction chemotherapy (IC) is widely used in this patient …

Advanced locoregional disease is the most frequent clinical situation in Head and Neck
cancer. The standard of care for most clinicians is a multidisciplinary treatment with …

The treatment of patients with locoregionally advanced squamous cell carcinoma of the
head and neck (HNSCC) is still evolving into the perfect combination of the different …

Background The value of induction chemotherapy (ICT) remains under investigation despite
decades of research. New advancements in the field, specifically regarding the induction …

Chemoradiotherapy as an alternative to surgery can be offered to patients affected by loco-
regionally advanced head and neck cancer (HNC). Induction chemotherapy is a valid …

The addition of chemotherapy to radiotherapy in the treatment of locally advanced
squamous cell carcinoma of the head and neck (SCCHN) patients improves survival. Meta …

Squamous cell carcinomas of the head and neck are highly responsiveto induction
chemotherapy. However, randomized trials have failedto demonstrate a survival advantage …

5578 Background: Induction chemotherapy plus CRT vs. CRT as front line treatment have
not been compare in LAHNC in randomised study. Recently, Zorat et al reported benefit in …